Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OnixCann is a Brazilian healthtech and medical-cannabis company focused on connecting patients with physicians and providing access to regulated medicinal cannabis products in Brazil. The company appears to operate as a distributor and commercialization platform for phytocannabinoid-based products rather than as a traditional drug-discovery biotech. Its business model combines physician and patient support, product distribution, medical education, and a digital platform called CanTera. Publicly available information also indicates that OnixCann has pursued partnerships for product development, clinical trials, and regulatory registration in Brazil, including work related to cannabis-based medicines and broader pharmaceutical opportunities. The company has launched branded CBD products in the Brazilian market and positions itself around safe, modern medicinal cannabis access from prescription through delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OnixCann.